agencies, and private organizations dealing with sport and fitness [2] . Various tests have been used to assess fitness. These are the Modified Bruce Treadmill Test, 12-Minute Run Test, 20-Meter Shuttle Test, etc. [3] the 6MWT is one such test used to assess fitness and cardiovascular endurance. 6MWT was developed in 1963 by Balke to evaluate functional capacity. The test was developed in frail elderly patients 60-90 years of age referred to a geriatric hospital and it targets community dwelling frail elders. Purpose of the 6 Minute Walk Test (6MWT) is to test exercise tolerance Fitness is a set of physical attributes related to a person's ability to perform physical activity successfully, without undue strain and with a margin of safety [1] . Participating in physical activity is beneficial to people of all ages. Physical activity contributes to fitness, a state in which people's health characteristics and behaviors enhance the quality of their lives [1] . Measurement of physical fitness in children and youth has long been a topic of interest to physical educators, exercise scientists, health in chronic respiratory disease and heart failure. However, the test has been useful in variety of chronic disease in adult and pediatric population as well as in healthy adults [4] . The test has been used in various diseases such as Alzheimer's, children fibromyalgia, geriatrics, heart failure, Multiple Sclerosis, Parkinson's disease, pulmonary disease, Osteoarthritis, spinal cord disease and Stroke. It assesses the distance walked in 6 minutes as a sub maximal test of aerobic capacity/ endurance. Its domain being motor, it does not require training nor any cost. The test age ranges from pre-school children ageing 2-5 yrs to elderly adults 65 plus [5] . The test is simple to perform. The person simply walks at a comfortable pace for a total of 6 mins. He may use a assistive device like a cane or a walker. He is also allowed to rest between the tests if needed. The total distance that the person walks during the 6 MWT is his score. If he is unable to complete the time period, the score becomes the distance walked and the time is also recorded. It can be administered anywhere. Often in hospitals, physical therapy settings, but can also be performed in outpatient clinic [6] . The test is widely being utilized in pediatric population. It has been used as an estimate of physical fitness in, for example; children with severe cardiopulmonary disease, Cystic Fibrosis and Juvenile idiopathic arthritis, etc [7] . There have been some studies of the 6 minute walk as a test of exercise or aerobic capacity in children (either who were considered healthy or those with varying chronic conditions) [8] [9] [10] [11] . Age, height, and weight are often factors that affect 6 minute walk times [8] [9] [10] [11] . Reliability estimates (ICC) in children range from Â 0.96 -0.98 and minimal clinically important differences are highly variable and likely depend heavily on the type of chronic condition [12] . Among children with juvenile idiopathic arthritis (JIA), the 6 minute walk was associated with sub maximal levels of exercise intensity suggesting it is a good measure of functional capacity [11] . Recently the 6MWT has been used as an outcome measure in weight loss studies and may be a practical and promising assessment tool for exercise performance in the obese pediatric population [13, 14] .
Most daily activities are performed at sub maximal levels of exertion and, therefore, it has been proposed that sub maximal functional tests are a better reflection of physical capability [15] . A recent review of functional walking tests concluded that the 6-min walk test (6MWT) is easier to carry out, more acceptable and provides a better reflection of activities of daily living than other walk tests [15] . The test has been used in PFT labs, Pediatrics, Cardiology, Cardiac and Pulmonary Rehab, Primary Care, (Pulmonary, Cardiologist, Pediatricians, COPD), Clinical Trials, Allied health education, PT, Nursing [16] . Because the test reflects an exercise level close to that of daily life activities, it is easy to administer, is well tolerated by patients, and is increasingly being used as a functional outcome measure for people with chronic conditions, including pediatric populations [17] . For example, the 6MWT has been utilized as a functional outcome measure in recent intervention studies including children with mucopolysaccharidosis type 1 [17, 18] , Duchene muscular dystrophy [17, 19] , spina bifida, [17] [18] [19] [20] and obesity [17, 21] . Knowledge on the reproducibility and validity in relation to the 6MWT will enable the clinician to determine in which pediatric conditions and for what purpose the 6MWT is appropriate to use in his or her daily physical therapist practice [17] . Procedure: A literature search was performed using CINAHL, PEDro and Google Scholar. Additional searches were performed using the internet where the used phrases were '6MWT' or '6MWT in paediatric conditions' in full-text and conditions like 'asthma', 'cerebral palsy', etc in paediatric population in the title abstract keyword section. Reference lists of papers identified were read to identify additional papers. Additional information was gathered through authors, teachers, and study sponsors. Articles and research work appearing on the above searches from august 2013 up to December 2013 were included. The articles were studied for 6MWT procedure with reference to ATS guidelines. Those fulfilling ATS guidelines were selected and included for further analysis (Table  No . 1). Articles were assessed on the basis of PRISMA guidelines and analysis for the review was done. Level of evidence: strong_consistent findings in multiple studies of good methodological quality or in one study of excellent methodological quality, moderate_consistent findings in multiple studies of fair methodological quality or in one study of good methodological quality, limited_one study of fair methodological quality, conflicting_conflicting findings, unknown_only studies of poor methodological quality Thompson et al [35] Congenital heart disease (N_17) Age: 13.5 (0. Eighteen studies matched the inclusion criteria and were included in the systematic review. The reference checking of the included studies did not generate additional relevant studies. Reproducibility and validity of the 6MWT were evaluated in the following 9 patient groups: cystic fibrosis (n=3), cerebral palsy (n=2), obesity (n=4), juvenile idiopathic arthritis (n=2), Duchenne muscular dystrophy (n=2), congenital heart disease (n=1), acute lymphoblastic anaemia(n=1), asthma (n=2),generalized hyper mobility (n=1)
RESULTS

DATA SYNTHESIS AND ANALYSIS
Comparison of 6MWT testing procedures: Test procedures showed large variation. The walk-ing course ranged from 8 to 70 m, but was less than 30 m in approximately half of the studies. A pretesting resting period was applied in 40% of the studies. Encouragement was standardized in most of the studies. However, although studies followed the standardized phrases in accordance with ATS guidelines, other studies used continuous verbal encouragement. A safety chaser was defined as an assistant who walked behind the patient during the test and provided extra encouragement, assisted in the case of fall incidents, and performed additional measurements [31] . Reliability: Test-retest reliability was evaluated in 9 studies. The methodological quality of the studies on children with cystic fibrosis was rated fair [25, 29] and poor [24] . The quality of the studies on children with cerebral palsy was rated excellent (35) and fair [27] . The quality of the studies on children with Duchenne muscular dystrophy [31] , and obesity [33] was rated fair and good respectively. Main methodological flaws included inadequate statistical procedures, (24) inappropriate time intervals between tests (27-29) and ambiguity about independent administrations. (24, 27) Six studies reached high levels of test-retest reliability (ICC_.84 -.98), and 1 study showed a strong correlation between the test and retest, (rp_.90, P_.001). The level of evidence in the studies on children with Duchenne muscular dystrophy was reduced to limited because of their small sample sizes. Measurement error: Measurement error was evaluated in 8 studies. The methodological quality of the studies on children with cystic fibrosis was rated fair [24] . The quality of the studies on children with cerebral palsy was rated excellent and fair [35] . The quality of the studies on children with obesity [33] was rated good. The quality of the studies on children with congenital heart disease [32] and Duchenne muscular dystrophy [31] was rated fair and poor. Limits of agreement were determined in 6 studies and varied from _133 m to 101 m in children with cystic fibrosis [27] and from _14 m to 12 m in children with congenital heart disease [32] . Hypothesis testing (validity): Hypothesis testing was performed in studies, convergent validity was assessed in studies, and discriminative validity was assessed in studies. The methodological quality of the studies regarding children with obesity was rated fair [14, 28] and poor [33] . The quality of the studies on children with cystic fibrosis was rated fair [25] and poor [24] . The quality of the studies on children with Duchenne muscular dystrophy [31] , juvenile idiopathic arthritis [34] , was rated fair. The quality of the studies on children with cerebral palsy, and congenital heart disease [32] , was rated poor. Main methodological flaws included the absence of a predefined hypothesis [32, 38] inadequate statistical analysis [24, 32] and validity issues concerning test performance [31] .
Sample Size: The sample size in most of the included studies was small. In general, small sample sizes lead to reduction of power and hinder the ability to generalize the results to the reference population [39] . However, the required sample size to generate sufficient power in a study is not fixed but can be calculated based on the effect size and the significance criterion. Regrettably, none of the studies Reported a power analysis; therefore, it remained unclear whether the sample sizes were adequate. In the best evidence synthesis, studies on the same patient group with sufficient methodological quality were pooled to increase sample size and extend the level of evidence.
DISCUSSION
Eighteen studies were evaluated on both methodological quality and quality criteria of the measurement properties of the 6MWT in various pediatric conditions. The best evidence synthesis of the 18 included studies provides an overview of the current body of knowledge about the measurement properties of the 6MWT in various pediatric conditions. Methodological Considerations: The methodological quality of the studies varied between poor and excellent. Notably, the studies on hypothesis testing received remarkably low ratings on methodological quality. These low ratings were due mainly to the fact that few studies formulated clearly defined hypotheses. Without specific hypotheses on expected mean differences between known groups or expected correlations with other variables, it remains unclear whether the results reflect the construct to be measured and only little can be said about the validity of the 6MWT [40] . The importance of a clear statement on expected correlations in the assessment of validity of the 6MWT is even more important if we consider that the construct to be measured with the 6MWT in a given population is not clearly described in most of the studies. Moreover, the particular construct of the 6MWT in each case seems to depend largely on both the origin and severity of the functional limitations. The 6MWT reflects maximal exercise capacity in pediatric patients with moderate to severe pulmonary and cardiovascular conditions such as cystic fibrosis [25] , congenital heart disease [32] but sub maximal exercise capacity in other chronic conditions [33, 34, 11] . This finding is in accordance with a prior study regarding the adult population [41] . Jehn et al [41] showed that the 6MWT reflects a maximum exercise response in patients with advanced heart failure, whereas it only constitutes a sub maximal exercise test in patients with mild heart failure and no functional limitations. Given the fact that the construct of the 6MWT depends on both the patient population and the disease severity, it seems no longer justified to label the 6MWT as a submaximal functional outcome measure before a proper validity assessment on the target population is performed, including both patients who are mildly and severely affected. Evaluative Properties of the 6MWT (Reliability and Measurement Error): The reproducibility of an instrument reflects both reliability and measurement error parameters. Whereas the first parameter refers to the ability to distinguish among individuals and is mostly important when used for discriminative purposes, the latter parameter refers to the ability of the instrument to detect relevant changes and is more suitable for evaluative purposes. The resent systematic review provides sufficient evidence that the 6MWT is capable of distinguishing not only between children with various conditions and their peers who are healthy but also within patient populations. Although the measurement error for several subgroups has been determined, the evaluative value of the 6MWT remains unclear. All studies on measurement error received an "indeterminate" rating. Clinical Implications: Clinicians can use the results of this study to support their diagnostic process and evaluation of interventions in children with various conditions. The best evidence synthesis provides a clear overview of the current knowledge of the reliability and validity of the 6MWT in specific conditions and can guide clinicians in their decision of whether to use the 6MWT and in interpreting the outcome. If a clinician, for example, wants to evaluate physical fitness in a child with juvenile idiopathic arthritis, he or she might consider the 6MWT. The best evidence synthesis of studies of juvenile idiopathic arthritis, however, shows that the 6MWT is likely to be a poor indicator for aerobic capacity and that it is unknown whether the 6MWT provides reproducible test results. Based on this information, a clinician will possibly decide to use another outcome measure such as the maximal cardiopulmonary exercise test. The lack of evidence for the measurement properties of the 6MWT for many pediatric conditions does not automatically mean that the 6MWT cannot be applied. It does demand a critical approach of the clinician to the aim and the results of the test. Without knowledge about the construct of the 6MWT for a specific population and the measurement error between repeated measurements, results should be interpreted with caution and alternative outcome measures must be considered.
CONCLUSION
Evidence for measurement properties of the 6MWT varies greatly among pediatric conditions. Further research is needed in all patient groups to explore the ability of the 6MWT to measure significant and clinically important changes. Until further research is conducted, changes measured with the 6MWT should be interpreted with caution and attention should be paid to whether it is a meaningful change for the individual patient. Future studies toward consensus regarding modified test procedures in the pediatric population are recommended.
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